Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Minority Interest (2016 - 2025)

Historic Minority Interest for Lineage Cell Therapeutics (LCTX) over the last 16 years, with Q3 2025 value amounting to -$1.2 million.

  • Lineage Cell Therapeutics' Minority Interest rose 1063.22% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 1063.22%. This contributed to the annual value of -$1.4 million for FY2024, which is 193.41% up from last year.
  • According to the latest figures from Q3 2025, Lineage Cell Therapeutics' Minority Interest is -$1.2 million, which was up 1063.22% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Lineage Cell Therapeutics' Minority Interest registered a high of -$1.1 million during Q1 2021, and its lowest value of -$1.5 million during Q3 2023.
  • In the last 5 years, Lineage Cell Therapeutics' Minority Interest had a median value of -$1.4 million in 2025 and averaged -$1.3 million.
  • Its Minority Interest has fluctuated over the past 5 years, first surged by 3658.82% in 2021, then plummeted by 2422.08% in 2022.
  • Quarter analysis of 5 years shows Lineage Cell Therapeutics' Minority Interest stood at -$1.3 million in 2021, then fell by 6.05% to -$1.4 million in 2022, then grew by 0.5% to -$1.4 million in 2023, then rose by 1.93% to -$1.4 million in 2024, then rose by 9.13% to -$1.2 million in 2025.
  • Its Minority Interest was -$1.2 million in Q3 2025, compared to -$1.3 million in Q2 2025 and -$1.4 million in Q1 2025.